glioblastoma (Also glioblastomas) : Related Words Words similar in meaning to glioblastoma
- spongioblastoma«
- glioblastoma«
- tumor«
- brain tumour«
- patient«
- brain tumor«
- temozolomide«
- mgmt methylation«
- chemotherapy«
- surgery«
- radiation«
- symptom«
- temozolomide chemotherapy«
- primary glioblastoma«
- brain«
- secondary glioblastoma«
- glioblastoma multiforme«
- idh1 mutation«
- tumor stem cell«
- treatment«
- egfr«
- grade astrocytoma«
- survival«
- idh1«
- diagnosis«
- grade glioma«
- cell«
- therapy«
- treatment survival«
- mgmt enzyme«
- healthy astrocyte«
- glioblastoma activity«
- gbm tumor«
- gene«
- month improvement«
- electric field therapy«
- mass effect«
- cellular volume«
- glioblastoma patient«
- age«
- glioblastoma cell«
- methylation«
- mutation«
- glutamate«
- radiation therapy«
- anaplastic astrocytoma«
- alteration«
- prognosis«
- disease«
- lesion«
- trial«
- conventional therapy«
- headache«
- clinical trial«
- epidermal growth factor receptor«
- neurofibromatosis«
- glioma«
- malaria«
- toca«
- intracranial pressure«
- resection«
- clinical investigation«
- anticonvulsant«
- blood–brain barrier«
- dna«
- radiotherapy«
- tumor cell«
- ion channel«
- metastasis«
- corticosteroid«
- hemorrhage«
- edema«
- genetic disorder«
- necrosis«
- ct scan«
- subtype«
- stem cell«
- cancer cell«
- mri«
- cancer«
- expression«
- worse prognostic risk«
- widespread tumor infiltration«
- vector producer cell efficiency«
- variable ring«
- unmethylated mgmt promoter«
- type idh1-enzyme«
- tumor metabolite concentration«
- tumor b«
- term glioblastoma multiforme«
- symptomatic therapy«
- survival improvement«
- suicide repair mechanism«
- subtotal tumor resection«
- subsequent clinical research«
- subgroup dependent«
- specific tumor immune reaction«
- sinuous extracellular matrix«
- shortest survival«
- secondary gbms«
- secondary gbm >80 %«
- reverse capacity«
- relative cerebral blood volume«
- proneural subtype«
- primary supportive agent«
- primary gbm«
- previous radiation therapy«
- positive prognostic marker«
- pi3k/akt. glioblastoma«
- perfusion mri«
- participant randomized«
- other modalities«
- occasional pleocytosis«
- obvious tumor«
- nonradiation therapy«
- neurological deficit due«
- neural subtype«
- natural compound perillyl alcohol«
- most glioblastoma tumor«
- mgmt gene promoter«
- methylated mgmt promoter«
- mesenchymal subtype«
- meningeal gliomatosis«
- medication temozolomide«
- maximal tumor«
- li fraumeni syndrome«
- karnofsky performance score«
- intranasal drug delivery«
- intermediate survival«
- initial karnofsky performance score«
- inhomogeneous mass«
- idh1-mutated glioblastoma«
- idh1 wild«
- idh1 gene encodes«
- hypodense center«
- hyperplastic blood vessel«
- high dose steroid«
- hhv-6 reactivates«
- healthier time«
- glioblastoma underwent anticonvulsant treatment«
- glioblastoma tumor cell«
- glioblastoma multiforme prognosis«
- glioblastoma due«
- gene encoding isocitrate dehydrogenase-1«
- gene delivery vehicle«
- gbm free«
- feasible resection«
- endpoint definition«
- dimensional conformal radiotherapy«
- dense tumor structure«
- decade significant advance«
- current conventional cancer treatment«
- complete initial removal«
- clinical phase i/ii study«
- classic infiltration«
- choline peak«
- chemotherapy radiosensitizers«
- cell hybridoma vaccine«
- brain drug delivery«
- bevacizumab control symptom«
- average gbm tumor«
- analysis link brain cancer«
- aid glioblastoma cell«
- aggressive invasive behavior«
- nausea«
- drug«
- phase«
- undergrading«
- uncommon risk factor«
- ucla neuro«
- type glioblastoma«
- time survival data«
- rindopepimut«
- oncometabolite«
- normal brain cell«
- neuron marker«
- microrna«
- maximum treatment«
- malignant portion«
- intranasal delivery«
- glioblastoma stem«
- glioblastoma multiforme tumor«
- gene tp53«
- gene predictor«
- gbm cell«
- gbk potassium channel«
- gabra1«
- frontal lobe involvement«
- fewer alteration«
- experimental brain tumor animal model«
- clc-3 chloride channel«
- brain tumor incidence«
- astrocytoma who grading lecture handout«
- month«
- type platelet«
- tumor blood flow«
- tumefactive multiple sclerosis«
- transcription factor hes3«
- term survival benefit«
- standard radiation«
- progressive memory«
- peritumoral edema«
- pathologic confirmation«
- mutational status«
- glioblasts«
- gbm patient«
- enzyme isocitrate dehydrogenase«
- cancer stem cell property«
- virus sv40«
- tocagen«
- syt1«
- slc12a5«
- secondary resistance«
- prognostic power«
- invasive behaviour«
- direct nose«
- brain radiotherapy«
- primitive precursor«
- preclinical animal study«
- mgmt gene«
- idh1 gene«
- gene transfer technology«
- dna alkylation«
- d-2-hydroxyglutarate«
- complete july«
- antiangiogenic therapy«
- approach«
- standard mri«
- recurrent glioblastoma«
- radiosensitizers«
- mr spectroscopy«
- healthy cell unharmed«
- dna characteristic«
- chemotactic signal«
- total radiation dose«
- stereotactic biopsy«
- prevalent symptom«
- percival bailey«
- pathological property«
- pathological diagnosis«
- glutamate concentration«
- egfr gene«
- trans sodium crocetinate«
- quick adaptation«
- pivotal clinical trial«
- gross total resection«
- american brain tumor association«
- screening«
- turcot syndrome«
- tumor grade«
- total resection«
- death return«
- seizure«
- pathway«
- target disease«
- repair capacity«
- patient prognosis«
- anaplastic cell«
- % form«
- medication«
- tumor resection«
- improved response«
- external beam radiation«
- recurrent tumor«
- molecular biomarkers«
- asymptomatic condition«
- palliative therapy«
- pdgfra«
- other modality«
- primary brain tumor«
- pathology specimen«
- genetic event«
- clinical trial design«
- tissue«
- variable appearance«
- neurofibromin«
- methylation status«
- cerebral white matter«
- presence«
- nefl«
- complicating factor«
- cure«
- tumor removal«
- regulatory guidance«
- neurologic function«
- type approach«
- standard dos«
- commercial feasibility«
- larger trial«
- ion movement«
- preclinical model«
- normal expression«
- boron neutron capture therapy«
- astrocytomas«
- male«
- lindau disease«
- ventricular wall«
- recurrent disease«
- grade tumor«
- median survival time«
- hypoxic environment«
- chemotherapeutics«
- fraumeni syndrome«
- tumor biology«
- brain metastasis«
- oxygen diffusion«
- palliative treatment«
- environmental chemical«
- treatment regime«
- dna transcription«
- similar trial«
- aggressive cancer«
- multiform«
- free margin«
- cells«
- various approach«
- supportive treatment«
- drug concentration«
- growth factor receptor«
- dna repair enzyme«
- anopheles mosquito«
- erythema multiforme«
- tumor size«
- von hippel«
- molecular characterization«
- many drug«
- numerous alteration«
- median survival«
- high dos«
- tissue biopsy«
- chemotherapy agent«
- other risk factor«
- conclusive result«
- worse prognosis«
- stevens–johnson syndrome«
- craniotomy«
- hemiparesis«
- metabolism«
- harvey cushing«
- common mutation«
- retrospective analysis«
- recurrence rate«
- tuberous sclerosis«
- promising approach«
- genetic alteration«
- skin reaction«
- common length«
- survival time«
- cerebral edema«
- normal population«
- study due«
- gene transfer«
- personality«
- palliative«
- conventional treatment«
- extra copy«
- free survival«
- malignant cell«
- hypersensitivity reaction«
- arteriole«
- human clinical trial«
- randomized clinical trial«
- symptom similar«
- cytomegalovirus«
- rna interference«
- meninges«
- fluorescent dye«
- laboratory research«
- most study«
- critical evaluation«
- definitive diagnosis«
- upregulation«
- poor prognosis«
- immunosuppression«
- immunohistochemistry«
- corpus callosum«
- low toxicity«
- biomarker«
- alternative treatment«
- distant location«
- glial cell«
- statin«
- potential treatment«
- tissue culture«
- pathogenesis«
- genetic predisposition«
- immunotherapy«
- cerebrum«
- protein content«
- glutamine«
- enormous size«
- mri scan«
- term benefit«
- hydrocephalus«
- initial result«
- alleviation«
- benefit«
- promising result«
- test«
- link«
- medical expert«
- rate«
- risk«
- osmosis«
- drowsiness«
- limited capacity«
- people«
- viral replication«
- gene therapy«
- cerebrospinal fluid«
- sign«
- common symptom«
- abscess«
- memory loss«
- aerosol«
- neurosurgeon«
- combination«
- ventricle«
- caucasian«
- hypoxia«
- cyst«
- unconsciousness«
- alcohol consumption«
- lymphocyte«
- molecular«
- similar appearance«
- biopsy«
- degeneration«
- electromagnetic field«
- subtypes«
- dna test«
- brain cancer«
- neurotransmitter«
- result«
- movement«
- rearrangement«
- select«
- immune response«
- relapse«
- energy source«
- gold standard«
- cell membrane«
- population«
- oncology«
- response«
- subsequent«
- hemisphere«
- vomiting«
- risk factor«
- limited success«
- spinal cord«
- recurrence«
- imaging«
- central nervous system«
- antibody«
- median«
- hispanic«
- plasma«
- original site«
- 60–65 gy«
- 5-aminolevulinic acid«